SPIRIVA HANDIHALER 18 MCG CAP

What it is

SPIRIVA HANDIHALER 18 MCG CAP is how the CMS NADAC file names this product. The FDA NDC Directory lists it as tiotropium bromide, under the trade name “Spiriva HandiHaler”.

FDA gives its dosage form as capsule and its route as oral; respiratory (inhalation).

The labeler, the company named on the label, is Boehringer Ingelheim Pharmaceuticals, Inc.

FDA’s Established Pharmacologic Class for it is Anticholinergic.

The NADAC file of 2026-10-14 prices it under 3 NDCs (National Drug Codes).

NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $10.60 – $11.68 for 1 capsule, depending on the NDC ($10.60481 to $11.679 per EA), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size.

NADAC also lists, on the row of one brand NDC, what pharmacies pay for the generic equivalent, a different product: $11.81093 per EA filed.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What NADAC measures · NADAC explanation codes

All 3 NDCs

• 00597-0075-41 · Boehringer Ingelheim Pharmaceuticals, Inc. · $10.60481 per EA · eff. 2026-09-23 filed
• 00597-0075-47 · Boehringer Ingelheim Pharmaceuticals, Inc. · $10.61989 per EA · eff. 2026-09-23 filed
• 00597-0075-75 · Boehringer Ingelheim Pharmaceuticals, Inc. · $11.679 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

1 other product in the NADAC file shares the FDA nonproprietary name tiotropium bromide with SPIRIVA HANDIHALER 18 MCG CAP.

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 3 NDCs’ NADAC prices is $10.61989 per EA filed.

Of the 23 other products in FDA’s Anticholinergic class priced per EA, 5 have a higher middle NADAC price and 18 a lower one. The one in the middle is LOMOTIL 2.5-0.025 MG TABLET, at $2.99096 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

How the class comparison works

What Medicare paid

Medicare Part D paid $16.60 for 1 capsule, at an average of $16.60372 per EA in 2024 (2024-01-01 to 2024-12-31) for “Spiriva Handihaler” and “Tiotropium Bromide”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 619,477 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

• What is your cash price for 1 capsule? Is it lower than what I would pay through my insurance?
• Which NDC (the 11-digit number on the package) is this? Pharmacies pay $10.60481 to $11.679 per EA for this product, depending on the NDC.
• Is a generic version available, and would it suit me? NADAC lists a generic with the same ingredient, strength and dosage form by FDA: TIOTROPIUM 18 MCG CAP-INHALER. Ask your pharmacist or prescriber; do not switch on your own.
• If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
• These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.